Abstract

Rodent pancreatic β-cells that naturally lack hypoglycemia/hypoxia inducible mitochondrial protein 1 (HIMP1) are susceptible to hypoglycemia and hypoxia influences. A linkage between the hypoglycemia/hypoxia susceptibility and the lack of HIMP1 is suggested in a recent study using transformed β-cells lines. To further illuminate this linkage, we applied mouse insulin 1 gene promoter (MIP) to control HIMP1-a isoform cDNA and have generated three lines (L1 to L3) of heterozygous HIMP1 transgenic (Tg) mice by breeding of three founders with C57BL/6J mice. In HIMP1-Tg mice/islets, we performed quantitative polymerase chain reaction (PCR), immunoblot, histology, and physiology studies to investigate HIMP1 overexpression and its link to β-cell function/survival and body glucose homeostasis. We found that the HIMP1 level increased steadily in β-cells of L1 to L3 heterozygous HIMP1-Tg mice. HIMP1 overexpression at relatively lower levels in L1 heterozygotes results in a negligible decline in blood glucose concentrations and an insignificant elevation in blood insulin levels, while HIMP1 overexpression at higher levels are toxic, causing hyperglycemia in L2/3 heterozygotes. Follow-up studies in 5–30-week-old L1 heterozygous mice/islets found that HIMP1 overexpression at relatively lower levels in β-cells has enhanced basal insulin biosynthesis, basal insulin secretion, and tolerances to low oxygen/glucose influences. The findings enforced the linkage between the hypoglycemia/hypoxia susceptibility and the lack of HIMP1 in β-cells, and show a potential value of HIMP1 overexpression at relatively lower levels in modulating β-cell function and survival.

Highlights

  • Pancreatic b-cell failure in diabetes is characterized primarily by progressive loss of insulin production and b-cell mass. b-cell failure has been attributed to autoimmune assault in type 1 diabetes and to glucolipotoxicity, amyloid deposition, insulin resistance, and endoplasmic reticulum (ER) and/or oxidative stress in type 2 diabetes [1,2,3,4,5,6,7]

  • Three transgenic founders were identified by amplification of a DNA fragment (364 bp) from the mouse insulin gene promoter (MIP)-hypoxia inducible mitochondrial protein 1 (HIMP1) expression cassette rather than natural HIMP1 gene in the genome of mouse as described in the Materials and Methods

  • The differences in the level of the MIPHIMP1 expression cassette DNA (Fig. 1B) may result from variations in the number of MIP-HIMP1 DNA integrated in genome, which may potentially be responsible for discrepancies in the phenotype of HIMP1-Tg mice between 3 lines

Read more

Summary

Introduction

Pancreatic b-cell failure in diabetes is characterized primarily by progressive loss of insulin production and b-cell mass. b-cell failure has been attributed to autoimmune assault in type 1 diabetes and to glucolipotoxicity, amyloid deposition, insulin resistance, and endoplasmic reticulum (ER) and/or oxidative stress in type 2 diabetes [1,2,3,4,5,6,7]. The lack of regular blood flows in early hours of islet transplantation leads to insufficient supplies of oxygen and nutrients (e.g., glucose) within implanted islets This hypoglycemia/hypoxia influence is implicated in b-cell damages within implanted islets, which limits a long-term success of this technique for patients with type 1 diabetes in clinical practice [8,13,14,15,16]. Proinsulin, the predominant form of insulin precursor in the ER, preserves a low relative folding rate, and bears the greatest burden in the protein folding of b-cells It maintains a homeostatic balance of natively and plentiful non-natively folded states (i.e., proinsulin homeostasis, PIHO) in b-cells as a result of the integration of maturation and disposal processes [18]. The low relative folding rate and plentiful insulin precursor manufactured in b-cells make PIHO susceptible to genetic and environmental influences, and PIHO disorder has been critically linked to defects in b-cells in diabetes [18]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call